Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
RESEARCH TOOLSreports
BioRestorative Therapies (BRTX) Stock Price & Analysis
130 Followers
BRTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.20 - $7.13
Previous Close$1.37
Volume362.93K
Average Volume (3M)960.58K
Market Cap
$9.27M
Enterprise Value-$2.77M
Total Cash (Recent Filing)$12.24M
Total Debt (Recent Filing)$198.72K
Price to Earnings (P/E)-0.4
Beta0.71
Next Earnings
May 14, 2024EPS Estimate
-$0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.54
Shares Outstanding6,769,919
10 Day Avg. Volume1,877,568
30 Day Avg. Volume960,577
Standard Deviation22.00
R-Squared0.02
Alpha2.10
Financial Highlights & Ratios
Price to Book (P/B)0.80
Price to Sales (P/S)77.42
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-21.24
Enterprise Value/Gross Profit-23.08
Enterprise Value/Ebitda0.57
Forecast
1Y Price Target
$10.50Price Target Upside619.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
BioRestorative Therapies News
Options Prices
Currently, No data available
---
Ownership Overview
37.63% Insiders
2.40% Mutual Funds
0.82% Other Institutional Investors
59.15% Public Companies and
Individual Investors
BRTX FAQ
What was BioRestorative Therapies’s price range in the past 12 months?
BioRestorative Therapies lowest stock price was $1.20 and its highest was $7.13 in the past 12 months.
What is BioRestorative Therapies’s market cap?
Currently, no data Available
When is BioRestorative Therapies’s upcoming earnings report date?
BioRestorative Therapies’s upcoming earnings report date is May 14, 2024 which is in 11 days.
How were BioRestorative Therapies’s earnings last quarter?
BioRestorative Therapies released its earnings results on May 15, 2018. The company reported -$1560 earnings per share for the quarter, missing the consensus estimate of N/A by -$1560.
Is BioRestorative Therapies overvalued?
According to Wall Street analysts BioRestorative Therapies’s price is currently Undervalued.
Does BioRestorative Therapies pay dividends?
BioRestorative Therapies does not currently pay dividends.
What is BioRestorative Therapies’s EPS estimate?
BioRestorative Therapies’s EPS estimate is -$0.51.
How many shares outstanding does BioRestorative Therapies have?
BioRestorative Therapies has 6,769,919 shares outstanding.
What happened to BioRestorative Therapies’s price movement after its last earnings report?
BioRestorative Therapies reported an EPS of -$1560 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of BioRestorative Therapies?
Currently, no hedge funds are holding shares in BRTX
---
BioRestorative Therapies Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.50 (619.18% Upside)
$10.50 (619.18% Upside)
Insider Transactions
Bought Shares
Worth $378.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.9%
Last 30 Days ▲ 10.6%
Last 30 Days ▲ 10.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-66.74%
12-Months-Change
Fundamentals
Return on Equity
-105.30%
Trailing 12-Months
Asset Growth
-23.26%
Trailing 12-Months
Company Description
BioRestorative Therapies
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. The ThermoStem Program focuses on treatments for metabolic disorders and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. It also offers plant stem cell-based facial creams and products under the Stem Pearls brand. Biorestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
---
BRTX Stock 12 Months Forecast
Average Price Target
$10.50
▲(619.18% Upside)
Technical Analysis
Best Analysts Covering BRTX
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-52.80%
reiterated a buy rating 18 days ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -52.80% per trade.
---